New Enterprise Associates 15, L.P.'s Net Worth
$1.05 Billion
Who is New Enterprise Associates 15, L.P.?
New Enterprise Associates 15, L.P. has an estimated net worth of $1.05 Billion. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., NeueHealth, Inc., AVEO PHARMACEUTICALS INC, IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.
SEC CIK
New Enterprise Associates 15, L.P.'s CIK is 0001629794
Past Insider Trading and Trends
2021 was New Enterprise Associates 15, L.P.'s most active year for acquiring shares with 13 total transactions. New Enterprise Associates 15, L.P.'s most active month to acquire stocks was the month of September. 2021 was New Enterprise Associates 15, L.P.'s most active year for disposing of shares, totalling 16 transactions. New Enterprise Associates 15, L.P.'s most active month to dispose stocks was the month of September. 2021 saw New Enterprise Associates 15, L.P. paying a total of $48,559,350.00 for 194,673,353 shares, this is the most they've acquired in one year. In 2019 New Enterprise Associates 15, L.P. cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Berkshire Grey, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.18M |
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nightstar Therapeutics plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.66M |
$25.50 | -$169,894,566.00 |
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.79M |
$15.00 |
—
| 4.79M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcellx, Inc. (ACLX) Snapshot price: $71.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.65% | -2.00M |
—
|
—
| 4.75M |
Dec 20
| |||
Form 4
| +4.86% | 312.5K |
$16.00 | $5,000,000.00 | 6.75M |
Jun 21
| |||
Form 4
|
∞
| 6.43M |
$15.00 | $23,749,995.00 | 6.43M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IonQ, Inc. (IONQ) Snapshot price: $6.792
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.44% | -11.69M |
—
|
—
| 14.61M |
Nov 16
| |||
Form 4
| -10.00% | -2.92M |
$5.84 | -$17,073,458.62 | 26.31M |
May 26 - May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||